Skip to main content
Premium Trial:

Request an Annual Quote

Stat-Diagnostica Raises $22.1M in Private Financing Round

NEW YORK (GenomeWeb News) – Stat-Diagnostica today announced that it has raised €17 million ($22.1 million) in a Series B financing round.

The Barcelona, Spain-based firm said that it will use the funds to complete development of its Near Patient Testing diagnostic system and to clinically validate its first products. The test platform combines molecular and immunoassay techniques in a single device and can provide results in less than 30 minutes, the company said.

Clinical applications will initially focus on testing for infectious diseases, antibiotic resistance, and detection of biomarkers in critically ill patients, said Stat-Diagnostica.

"The Series B financing is a significant milestone that will support our preparation for a European market launch in 2015," Jordi Carrera, CEO and co-founder of Stat-Diagnostica, said in a statement. "Our ability to close the round is proof of the outstanding team behind the company and demonstrates the potential of our technology in the fast growing decentralized diagnostics market."

The financing round was led by new investor Kurma Life Sciences Partners and included the participation of other new investors including Idinvest, Boehringer Ingelheim Venture Fund, and Caixa Capital Risc. Existing investors Ysios Capital and Axis also participated in the Series B round.

Stat-Diagnostica noted that Ysios Capital has become the company's largest shareholder through its latest investment in the firm.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.